-VISIT OUR OTHER FORUMS- OB-GYN-L Ultrasound Ultrasound History Fibroid Forum Physicians-in-Training Tech Talk OBSTET-L (portuguese) OBGIN-L (spanish) Nursing

Re: Lost IUD From: Dr. John Provatopoulos B.Sc. M.D.C.M. F.R.S.C. (johnprov@sympatico.ca) Tue Mar 27 10:17:56 2007 Messages sorted by: [ date ][ thread ][ subject ][ author ] Next message: Dr. John Provatopoulos B.Sc. M.D.C.M. F.R.S.C.: "Re: Lost IUD" Previous message: Doc Peró: "Re: Lost IUD" In reply to: Atkinson, Samuel M: "Re: Lost IUD" Next in thread: Dr. John Provatopoulos B.Sc. M.D.C.M. F.R.S.C.: "Re: Lost IUD" Reply: Dr. John Provatopoulos B.Sc. M.D.C.M. F.R.S.C.: "Re: Lost IUD" Great thread awesome info, apparently perforation is not that unprecedented. Google is your friend. http://www.hc-sc.gc.ca/dhp-mps/medeff/bulletin/carn-bcei_v16n1_e.html#2 Levonorgestrel-releasing intrauterine system (Mirena) and uterine perforation The levonorgestrel-releasing system Mirena, an intrauterine device (IUD), consists of a polyethylene T-shaped frame with a reservoir containing levonorgestrel.1 Mirena is indicated for use as a contraceptive and, after insertion into the uterus, continuously releases levonorgestrel at a low daily dose for up to 5 years. Mirena's contraceptive action is due mainly to local progestogenic effects on the uterine cavity, including a strong antiproliferative effect on the endometrium and a thickening of the cervical mucus, which prevents the passage of sperm. Ovulation is inhibited in some women. As of Nov. 28, 2005, the product monograph (PM) states that perforation or penetration of the uterus or cervix may occur during insertion but that this is very rare (less than 1 in 10 000). It also states that postpartum insertions should be postponed until 6 weeks after delivery. >From Feb. 22, 2001 (the date of marketing in Canada), to Sept. 26, 2005, Health Canada received 26 reports of uterine perforation suspected of being associated with the use of Mirena. In 8 of the cases, Mirena was inserted between 6 weeks and 6 months post partum. A long-term prospective study of Mirena found a higher uterine perforation rate (0.9 per 1000 insertions) than that described in the PM2. With copper IUDs, the rate of uterine perforation has been 0.6-1.6 per 1000 insertions3, 4. In addition, evidence suggests that women who have IUDs inserted in the first 6 months post partum are at increased risk of uterine perforation5. This elevated risk may be due to the soft consistency of the uterus and the underestimated variability in uterine size during the first 6 months post partum. Uterine perforation is a rare but serious complication of IUD insertion that occurs or is initiated at the time of insertion.3 Evidence indicates that the rate of uterine perforation is lower in cases where the health care professional inserting the IUD has performed at least 10 previous insertions.4 Currently, there is a shortage of health care providers trained in IUD insertion; access to good knowledge, proper equipment and a mentor to demonstrate and supervise several insertions are prerequisites to providing this service3,6. Health care professionals inserting the levonorgestrel-releasing intrauterine system are encouraged to take this information into account. Special care should be taken with postpartum insertion, since perforations of the uterus have been reported7. Andrew Gaffen, BSc, DDS; Gina Coleman, MD, Health Canada. References Mirena (levonorgestrel-releasing intrauterine system) [product monograph]. Lachine (QC): Berlex Canada Inc.; 2000. Zhou L, Harrison-Woolrych M, Coulter DM. Use of the New Zealand Intensive Medicines Monitoring Programme to study the levonorgestrel-releasing intrauterine device (Mirena). Pharmacoepidemiol Drug Safety 2003;12:371-7. Society of Obstetricians and Gynaecologists of Canada. SOGC clinical practice guidelines: Canadian contraception consensus. J Obstet Gynaecol Can 2004;26(3):219-96. Harrison-Woolrych M, Ashton J, Coulter D. Uterine perforation on intrauterine device insertion: Is the incidence higher than previously reported? Contraception 2003;67(1):53-6. Caliskan E, Ozturk N, Dilbaz BO, et al. Analysis of risk factors associated with uterine perforation by intrauterine devices. Eur J Contracept Reprod Health Care 2003;8(3):150-5. Weir E. Preventing pregnancy: a fresh look at the IUD. CMAJ 2003;169(6):585. Backman T. Benefit-risk assessment of the levonorgestrel intrauterine system in contraception. Drug Safety 2004;27(15):1185-204. -- Take care, John Next message: Dr. John Provatopoulos B.Sc. M.D.C.M. F.R.S.C.: "Re: Lost IUD" Previous message: Doc Peró: "Re: Lost IUD" In reply to: Atkinson, Samuel M: "Re: Lost IUD" Next in thread: Dr. John Provatopoulos B.Sc. M.D.C.M. F.R.S.C.: "Re: Lost IUD" Reply: Dr. John Provatopoulos B.Sc. M.D.C.M. F.R.S.C.: "Re: Lost IUD"

Return to

Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Tue Sep 2 05:09:57 2008

The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.